Back to top
more

CVS Health (CVS)

(Delayed Data from NYSE)

$66.63 USD

66.63
12,908,298

-0.22 (-0.33%)

Updated Oct 11, 2024 04:00 PM ET

After-Market: $66.63 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 7% (233 out of 250)

Industry: Retail - Pharmacies and Drug Stores

Better trading starts here.

Zacks News

Factors Setting the Stage for Fred's (FRED) in Q4 Earnings

Fred's (FRED) has been reeling under soft comparable store sales for quite some time now. Let's see if Fred???s strategic initiatives can provide any respite in Q4.

    Can Strategic Efforts Aid Fred's to Achieve a Turnaround?

    Fred's (FRED) focuses on pharmacy organization and expense reduction to achieve turnaround. However, receding comps continue to hurt.

      Cigna to Take Over Express Scripts (ESRX) for $67 Billion

      Per a definitive agreement, Cigna will take over Express Scripts (ESRX) in a cash-and-stock transaction worth $67 billion.

        Why Is CVS Health Corporation (CVS) Down -9.2% Since its Last Earnings Report?

        CVS reported earnings 30 days ago. What's next for the company? We take a look at earnings estimates for some clues.

          Pharmacy Services Aid CVS Health, Aetna Deal an Upside Too

          CVS Health (CVS) is likely to earn $750 million from near-term synergies after the completion of Aetna acquisition deal.

            Walgreens (WBA) May Buy Remaining Stake in AmerisourceBergen

            Walgreens' (WBA) rumored buyout claim over the remaining stake in AmerisourceBergen comes close on the heels of its rival CVS Health's hefty $69-billion worth acquisition of health insurer, Aetna.

              Top Analyst Reports for Broadcom, Canadian National & CVS Health

              Today's Research Daily features new research reports on 16 major stocks, including Broadcom (AVGO), Canadian National (CNI) and CVS Health (CVS).

                CVS Health (CVS) Beats On Q4 Earnings & Revenues Estimates

                CVS Health (CVS) rides high on strength in Pharmacy Services segment in Q4.

                  Health Insurance Stock Outlook - January 2018

                  Rapid evolution is being witnessed in the health insurance industry as the players are taking concerted efforts to transform themselves into comprehensive health care providers from their earlier role of traditional payers.

                    Fred's (FRED) Sluggish Store Sales Keep Investors at Bay

                    Fred's (FRED) continues to witness dismal comps and store closures. Also, cancelled dividend and merger deal make this retailer a less-favored pick.

                      5 Reasons Why McKesson Deserves a Place in Your Portfolio

                      McKesson (MCK) continues to pursue deals, divestitures and acquisitions to drive growth. The company's impressive performance in 2017 accounts for its potential to sustain the momentum.

                        Company News For January 5, 2018

                        Companies In The News are:

                          CVS Health's (CVS) Outlook for 2018 Cheered by Investors

                          CVS Health (CVS) to witness increased cash flow of around $1.2 billion in 2018, courtesy the latest US Tax legislation.

                            Fred's Tanks 79% in a Year: Any Chances of Revival Ahead?

                            Fred's (FRED) has been struggling with its dismal comps performance stemming from receding traffic and store closures. Also, management cancelled its quarterly dividend recently.

                              Declining Comps Likely to Hurt Fred's (FRED) in Q3 Earnings

                              Fred's (FRED) third-quarter fiscal 2017 performance is expected to be hurt by dismal comps trend.

                                Company News For Nov 7, 2017

                                Companies In The News are: ON,BRK.B,S,TMUS,CVS

                                  McKesson (MCK) to Acquire RxCrossroads for $735 Million

                                  McKesson's (MCK) acquisition of RxCrossroads will boost its Specialty Health business.

                                    CVS Health (CVS) Beats On Q3 Earnings, Revenues In Line

                                    CVS Health (CVS) witnesses year over year growth in Pharmacy Services segment in Q3.

                                      Arpita Dutt headshot

                                      Is a CVS Health (CVS) - Aetna (AET) Deal in the Cards?

                                      Is an e-commerce company's interest in entering the drug pharmacy space the reason behind CVS Health's (CVS) interest in acquiring Aetna?

                                        Rite Aid (RAD) Slumps 14% Since Q2 Loss: What Lies Ahead?

                                        Rite Aid Corporation (RAD), which had quite an eventful journey of late, reported dismal second-quarter fiscal 2018 results last week. However, latest deal with Walgreens should benefit.

                                          Can Fred's Strategies Help It Counter Slow Comps & Traffic?

                                          Fred's (FRED) has been struggling with declining store traffic and sluggish comps over the past few quarters. The company has been focusing on cost reduction and internal restructuring.

                                            What FTC's Curtail on RAD Store Purchase Means for Walgreens?

                                            Walgreens' (WBA) purchase of lesser number of Rite Aid stores upsets investors. Let's draw an insight from this.

                                              Rite Aid Gets FTC Nod for Sale of Fewer Stores to Walgreens

                                              After four amendments, Rite Aid Corp. (RAD) and Walgreens Boots Alliance Inc. (WBA) finally received a nod for the fresh proposal the latter put forward yesterday.

                                                Ryan McQueeney headshot

                                                Why Did Rite Aid (RAD) Stock Crash Today?

                                                Shares of Rite Aid (RAD) fell more than 10% on Tuesday after Walgreens Boots (WBA) received government approval to buy fewer Rite Aid stores than had initially been proposed.

                                                  Walgreens to Revisit Rite Aid Deal for Antitrust Approval

                                                  The Federal Trade Commission ("FTC") seems to be getting harsher on drugstore chains Walgreens Boots Alliance Inc. (WBA) and Rite Aid Corp. (RAD), which have been trying to appease the regulatory body since its initial merger pact in 2015.